May 9, 2008: May 9, 2008
East Hall (Tampa Convention Center)
Catechol O-Methyltransferase (COMT) is an enzyme which degrades catecholamines, including epinephrine, norepinephrine, and dopamine. A common functional polymorphism of the COMT gene (Val 158Met) decreases COMT thermostability, resulting in a 3-4 fold reduction in COMT enzyme activity. The allelic affects are codominant, so that individuals with the met/met genotype have the least COMT enzyme activity. In animal models, it has previously been shown that heightened catecholamine levels increase pain sensitivity. In addition, it was recently reported that individuals with the COMT met/met genotype exhibit a lower cortisol response to the Trier Social Stress Test. We assessed the association between met/met genotype and cortisol response and pain symptoms after minor MVC. 47 adult Caucasians presenting to the emergency department (ED) for care after minor MVC were recruited. ED evaluation included serial ED cortisol assessment, blood collection for subsequent DNA analysis, and an assessment of neck pain symptom severity (0-10 NRS). Dissociative symptoms were also assessed (Michigan Critical Events Perception Scale). Genotyping was performed using the Sequenom Platform. Associations between COMT met/met genotype and cortisol response and pain symptoms were assessed via repeated measures analysis and t-test, respectively. Individuals with COMT met/met genotype had a reduced ED cortisol response (AUC .106 vs. 467, p = .05) and increased pain symptoms in the ED (6.9 vs. 3.0, p = .002) vs. other genotypes. Individuals with the met/met genotype also had more dissociative symptoms (16.1 vs. 11.4, p .002). In contrast, injury Severity Score, highest Abbreviated Injury Severity score, airbag deployment, and police officer rating of crash severity at the scene were poor predictors of pain outcomes. These data provide the first report of a link between genes influencing the stress response and the physiologic and symptom response to a traumatic event.
Support: UM Chronic Pain and Fatigue Research Center; TRYUMPH Research Program; NIHK23KAR050410A.
![[ Visit APS Website ]](images/banner.jpg)